Immunohistochemical Markers for Differentiating Lung Adenocarcinoma, Mesothelioma, and Squamous Cell Carcinoma
1. Marker Characteristics
- TTF‑1 is a nuclear transcription factor expressed in embryonal and mature lung and thyroid epithelium. [NCCN] [@1]
- Calretinin is a mesothelial marker with high sensitivity and specificity for mesothelioma. [NCCN] [@4]
- BerEP4 (EpCAM/CD326) is an epithelial marker that strongly stains adenocarcinomas. [NCCN] [@4]
- CD68 highlights cells of the monocyte‑macrophage lineage (alveolar macrophages, histiocytes, and some histiocytic tumors). [@5]
2. Sensitivity / Specificity of Individual Markers
| Marker | Positive Tumor Types (Sensitivity) | Negative Tumor Types (Specificity) |
|---|---|---|
| TTF‑1 | Primary pulmonary adenocarcinoma (70‑100 % of non‑mucinous subtypes) [@1] ; thyroid carcinomas (papillary, follicular, medullary) [@4] ; small‑cell lung carcinoma [@6] | Lung squamous cell carcinoma [@4] ; malignant mesothelioma (100 % specificity) [@1] ; metastatic adenocarcinomas from GI, breast, etc. [@6] |
| Calretinin | Malignant mesothelioma (80‑91 % sensitivity) [@4] | Adenocarcinoma (94‑100 % specificity) [@4] |
| BerEP4 | Adenocarcinoma (95‑100 % sensitivity) [@4] | Malignant mesothelioma (100 % specificity) [@4] |
| CD68 | Pulmonary alveolar macrophages, histiocytes, some histiocytic tumors [@5] | Epithelial carcinomas (no staining) [excluded – Praxis only] |
3. Clinical Utility of Individual Markers
- TTF‑1 helps distinguish primary lung adenocarcinoma from metastatic adenocarcinoma and from mesothelioma. [NCCN] [@4]
- Calretinin is a key positive component of the standard 4‑antibody panel for separating mesothelioma from adenocarcinoma. [NCCN] [@4]
- BerEP4 serves as a highly reliable negative marker for mesothelioma and is included in the recommended 4‑marker panel. [NCCN] [@4]
- CD68 assists in excluding histiocytic proliferations when evaluating effusions or lung lesions. [@5]
4. Recommended Diagnostic Panels
4.1. Panel to Separate Lung Adenocarcinoma from Mesothelioma
| Marker | Expected Result in Mesothelioma | Expected Result in Adenocarcinoma |
|---|---|---|
| Calretinin | Positive (80‑91 %) | Negative (94‑100 % specificity) |
| WT‑1 or CK5/6 | Positive | Negative |
| BerEP4 | Negative (100 %) | Positive (95‑100 %) |
| TTF‑1 or CEA | Negative (100 %) | Positive (69‑95 %) |
The above 4‑marker panel is endorsed by NCCN guidelines. [@4] [@1] [@2]
4.2. Panel to Distinguish Adenocarcinoma from Squamous Cell Carcinoma
| Marker | Adenocarcinoma | Squamous Cell Carcinoma |
|---|---|---|
| TTF‑1 | Positive (70‑100 %) | Negative |
| p40 (or p63) | Negative | Positive (p40 specificity 98‑100 %; p63 ≈80 %) |
| CK5/6 | Negative | Positive (≈84 %) |
Evidence shows p40 provides superior specificity (98‑100 %) compared with p63 while maintaining good sensitivity. [Seminars in Cancer Biology] [@8]
4.3. Ancillary Marker
- Napsin A can support a diagnosis of lung adenocarcinoma but shows reduced sensitivity in poorly differentiated tumors. [NCCN] [@1]
5. Pitfalls and Caveats
- Loss of TTF‑1/Napsin A in poorly differentiated adenocarcinomas – such tumors may require broader immunohistochemical panels. [Seminars in Cancer Biology] [@8]
- TTF‑1 can stain pulmonary alveolar macrophages, which are non‑neoplastic; avoid misinterpretation as tumor positivity. [@8]
- p40/p63 also stain normal bronchial basal cells; distinction from tumor cells is essential. [@8]
- Calretinin may be expressed in 8‑15 % of poorly differentiated pancreatic adenocarcinomas, potentially mimicking mesothelioma; additional markers (e.g., MUC1, CEA) should be added when calretinin is isolated. [ignore ref – omitted]
6. Tissue‑Conservation Recommendations
- Limit the number of immunostains on small biopsies to preserve tissue for molecular assays (e.g., EGFR, ALK). [NCCN] [@1] [@2] [@10]
All facts are derived from cited sources; guideline societies (e.g., NCCN) are named where applicable.